Actinium Pharmaceuticals, Inc. (ATNM) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 43.26M | 49.38M | 54.37M | 61.03M | 66.46M | 74.51M | 79.52M | 87.07M | 85.37M | 78.26M | 85.6M | 95.54M | 98.55M | 110.94M | 113.42M | 118.3M | 74.05M | 79.75M | 83.26M | 83.17M |
| Cash & Short-Term Investments | 42.13M | 48M | 53.39M | 59.93M | 65.33M | 72.9M | 78.66M | 86.04M | 84.06M | 76.68M | 82.98M | 91.28M | 94.52M | 108.91M | 111.81M | 116.33M | 72.02M | 77.83M | 82.08M | 81.96M |
| Cash Only | 42.13M | 48M | 53.39M | 59.93M | 65.33M | 72.9M | 78.66M | 86.04M | 84.06M | 76.68M | 82.98M | 91.28M | 94.52M | 108.91M | 111.81M | 116.33M | 72.02M | 77.83M | 82.08M | 81.96M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.13M | 1.38M | 0 | 1.1M | 0 | 357K | 860K | 1.03M | 0 | 226K | 2.62M | 4.26M | 399K | 396K | 394K | 442K | 442K | 442K | 1.18M | 1.21M |
| Total Non-Current Assets | 2.18M | 2.39M | 1.78M | 1.99M | 2.19M | 2.39M | 2.59M | 2.79M | 2.98M | 3.18M | 3.35M | 3.51M | 3.48M | 3.25M | 3.39M | 3.5M | 509K | 639K | 1.22M | 1.28M |
| Property, Plant & Equipment | 1.84M | 2.06M | 1.45M | 1.66M | 1.86M | 2.07M | 2.27M | 2.48M | 2.66M | 2.87M | 3.04M | 3.21M | 3.18M | 2.95M | 3.09M | 3.2M | 509K | 639K | 776K | 841K |
| Fixed Asset Turnover | - | - | 0.06x | - | - | - | - | - | - | 0.03x | - | - | - | - | 0.01x | 0.02x | 1.64x | 0.03x | 0.29x | 0.30x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 337K | 0 | 332K | 329K | 327K | 324K | 322K | 318K | 0 | 313K | 310K | 307K | 0 | 0 | 0 | 0 | 0 | 0 | 392K | 392K |
| Other Non-Current Assets | 0 | 335K | 0 | 0 | 0 | 0 | 0 | 0 | 316K | 0 | 0 | 0 | 304K | 302K | 300K | 299K | 0 | 0 | 50K | 50K |
| Total Assets | 45.44M | 51.77M | 56.15M | 63.02M | 68.65M | 76.9M | 82.11M | 89.86M | 88.35M | 81.44M | 88.94M | 99.05M | 102.03M | 114.19M | 116.82M | 121.8M | 74.56M | 80.39M | 84.48M | 84.45M |
| Asset Turnover | - | - | 0.00x | - | - | - | - | - | - | 0.00x | - | - | - | - | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -33.81% | -32.67% | -31.62% | -29.87% | -22.3% | -5.58% | -7.68% | -9.28% | -13.4% | -28.68% | -23.86% | -18.68% | 36.83% | 42.05% | 38.28% | 44.22% | -0.71% | 21.07% | 67.2% | 50.92% |
| Total Current Liabilities | 7.35M | 7.97M | 6.83M | 8.31M | 7.11M | 8.15M | 7.75M | 9.73M | 8.06M | 8.49M | 8.67M | 9.15M | 7.86M | 10.63M | 8.35M | 6.28M | 5.72M | 6.84M | 4.19M | 3.87M |
| Accounts Payable | 6.62M | 0 | 6.22M | 7.71M | 6.52M | 7.57M | 7.2M | 9.18M | 7.51M | 7.95M | 8.15M | 8.64M | 0 | 10.13M | 7.87M | 5.77M | 5.26M | 5.54M | 3.77M | 3.43M |
| Days Payables Outstanding | 2.71K | - | - | - | - | 3.33K | 3.73K | 4.02K | 3.26K | 3.72K | 3.86K | 3.76K | - | 5.14K | 2.84K | 2.79K | 3.55K | 3.13K | - | - |
| Short-Term Debt | 734K | 722K | 0 | 600K | 0 | 0 | 0 | 0 | 0 | 541K | 522K | 514K | 0 | 0 | 0 | 0 | 0 | 0 | 417K | 447K |
| Deferred Revenue (Current) | 0 | 35M | 35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | -27.75M | -35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.36M | 0 | 91K | 204K | 267K | 998K | 0 | 0 |
| Current Ratio | 5.89x | 6.20x | 7.96x | 7.34x | 9.35x | 9.14x | 10.25x | 8.95x | 10.59x | 9.21x | 9.87x | 10.44x | 12.53x | 10.44x | 13.58x | 18.83x | 12.94x | 11.66x | 19.87x | 21.47x |
| Quick Ratio | 5.89x | 6.20x | 7.96x | 7.34x | 9.35x | 9.14x | 10.25x | 8.95x | 10.59x | 9.21x | 9.87x | 10.44x | 12.53x | 10.44x | 13.58x | 18.83x | 12.94x | 11.66x | 19.87x | 21.47x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 35.78M | 35.97M | 35.53M | 35.69M | 35.84M | 35.99M | 36.15M | 36.3M | 36.43M | 36.57M | 36.69M | 36.82M | 36.95M | 37.08M | 37.21M | 37.34M | 2K | 3K | 4K | 82K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 785K | 972K | 533K | 690K | 843K | 993K | 1.15M | 1.3M | 1.43M | 1.57M | 1.69M | 1.82M | 1.95M | 2.08M | 2.21M | 2.34M | 2K | 3K | 4K | 82K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35M | 0 | 0 | 0 | 0 | 35M | 35M | 35M | 0 | 0 | 0 | 0 |
| Total Liabilities | 43.13M | 43.94M | 42.37M | 44M | 42.95M | 44.14M | 43.91M | 46.03M | 44.49M | 45.07M | 45.36M | 45.97M | 44.82M | 47.71M | 45.56M | 43.62M | 5.72M | 6.84M | 4.19M | 3.96M |
| Total Debt | 1.52M | 1.69M | 1.14M | 1.29M | 1.43M | 1.57M | 1.71M | 1.85M | 1.98M | 2.11M | 2.21M | 2.34M | 2.46M | 2.58M | 2.6M | 2.65M | 197K | 310K | 421K | 529K |
| Net Debt | -40.61M | -46.3M | -52.25M | -58.64M | -63.89M | -71.33M | -76.95M | -84.19M | -82.08M | -74.56M | -80.77M | -88.94M | -92.06M | -106.33M | -109.21M | -113.68M | -71.82M | -77.52M | -81.66M | -81.43M |
| Debt / Equity | 0.66x | 0.22x | 0.08x | 0.07x | 0.06x | 0.05x | 0.04x | 0.04x | 0.05x | 0.06x | 0.05x | 0.04x | 0.04x | 0.04x | 0.04x | 0.03x | 0.00x | 0.00x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 2.3M | 7.83M | 13.78M | 19.01M | 25.69M | 32.76M | 38.21M | 43.84M | 43.86M | 36.38M | 43.58M | 53.08M | 57.21M | 66.48M | 71.25M | 78.18M | 68.84M | 73.55M | 80.28M | 80.5M |
| Equity Growth % | -91.03% | -76.09% | -63.92% | -56.63% | -41.41% | -9.95% | -12.33% | -17.41% | -23.34% | -45.28% | -38.84% | -32.11% | -16.89% | -9.61% | -11.25% | -2.88% | -2.68% | 19.94% | 76.73% | 58.54% |
| Book Value per Share | 0.07 | 0.25 | 0.44 | 0.61 | 0.82 | 1.05 | 1.23 | 1.46 | 1.57 | 1.32 | 1.61 | 2.02 | 2.23 | 2.59 | 2.83 | 3.29 | 3.11 | 3.41 | 3.73 | 3.98 |
| Total Shareholders' Equity | 2.3M | 7.83M | 13.78M | 19.01M | 25.69M | 32.76M | 38.21M | 43.84M | 43.86M | 36.38M | 43.58M | 53.08M | 57.21M | 66.48M | 71.25M | 78.18M | 68.84M | 73.55M | 80.28M | 80.5M |
| Common Stock | 31K | 31K | 31K | 31K | 31K | 31K | 31K | 31K | 29K | 28K | 27K | 27K | 26K | 26K | 25K | 25K | 22K | 22K | 22K | 21K |
| Retained Earnings | -415.24M | -409.71M | -403.77M | -398.64M | -391.76M | -375.83M | -369.17M | -357.61M | -346.25M | -337.58M | -328.26M | -314.98M | -299.8M | -288.76M | -278.12M | -268.64M | -260.88M | -255.75M | -247.74M | -241.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -39K | -20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |